C. Richards

发表

Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

A. Roses, Caifu Chen, K. Kelnar, 2008 .

Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy.

C. Richards, E. Austin, B. E. Huber, 1995, Human gene therapy.

In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.

C. Richards, V. Knick, E. Austin, 1993, Cancer research.

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

C. Richards, S. T. Davis, E. Austin, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy.

C. Richards, T. Krenitsky, B. E. Huber, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.

S. Thorgeirsson, C. Richards, S. Short, 1990, Cancer research.

Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression.

C. Richards, B. E. Huber, 1993, Human gene therapy.

Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U)

J. A. Hill, R. Ferone, C. Richards, 1987, Antimicrobial Agents and Chemotherapy.

Cloning, purification, and properties of Candida albicans thymidylate synthase

R. Ferone, C. Richards, P. Ray, 1989, Journal of bacteriology.

Properties of Candida albicans

R. Ferone, C. Richards, P. Ray, 2022 .

Virus‐Directed Enzyme/Prodrug Therapy (VDEPT) Selectively Engineering Drug Sensitivity into Tumors

C. Richards, E. Austin, B. E. Huber, 1994, Annals of the New York Academy of Sciences.

Alterations in tumor angiogenesis associated with stable expression of the HIV tat gene

C. Richards, P. Wirth, J. Martin, 1992, Molecular carcinogenesis.

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase

K. Weinhold, C. Richards, T. Spector, 1987, Antimicrobial Agents and Chemotherapy.

Hepatocarcinogenesis Cooperation in ras and myc Importance of c-Hepatoma Cell Line Hep G 2 : Additional Evidence for the Gene in the Human ras Characterization of a Transforming N-Updated

S. Thorgeirsson, C. Richards, S. Short, 2006 .

Regulated expression of artificial chimeric genes contained in retroviral vectors: implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applications.

C. Richards, B. E. Huber, 1996, Journal of drug targeting.

The transcriptional control region of the human carcinoembryonic antigen gene: DNA sequence and homology studies.

C. Richards, A. Wolberg, B. E. Huber, 1993, DNA sequence : the journal of DNA sequencing and mapping.

VDEPT: An enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancer

C. Richards, E. Austin, B. E. Huber, 1995 .

O3-02-07: Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways

A. Roses, Caifu Chen, K. Kelnar, 2008, Alzheimer's & Dementia.